HB 52 Kentucky House · 2017 Regular Session

AN ACT relating to controlled substances. Amend 218A.010 to provide definitions for “fentanyl” and “fentanyl derivative”; amend KRS 218A.020 to allow the Office of Drug Control Policy to request that the Cabinet for Health and Family Services schedule fentanyl analogues not approved for human use by the United States Food and Drug Administration; amend KRS 218A.050 to include fentanyl analogues not approved for human use by the Food and Drug Administration as a Schedule I controlled substance; amend KRS 218A.142 to create the offense of aggravated fentanyl trafficking; amend KRS 218A.1412 to increase the penalties for trafficking in fentanyl.

Bill status in committee 1 of 4 stages cleared
Introduction
Oct 2016
Committee Review
Floor Vote
Governor
Introduced Oct 6, 2016 Last action Jan 3, 2017
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
1
Jan 3, 2017
Committee
To Judiciary (H)
legislature
Jan 3, 2017
Introduced
Introduced in House
legislature
Oct 6, 2016
Introduced
Prefiled by the sponsor(s).
legislature
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.